Kennedy Capital Management, Inc. Merrimack Pharmaceuticals Inc Transaction History

Kennedy Capital Management, Inc.

  • $4.27 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$12.02 - $13.41 $571,022 - $637,055
-47,506 Reduced 50.7%
46,202 $619,000
Q3 2023

Nov 14, 2023
BUY
$11.6 - $12.52 $25,543 - $27,569
2,202 Added 2.41%
93,708 $1.16 Million
Q2 2023

Aug 14, 2023
BUY
$12.02 - $13.07 $934,530 - $1.02 Million
77,748 Added 565.11%
91,506 $1.13 Million
Q1 2023

May 15, 2023
BUY
$11.35 - $12.32 $156,153 - $169,498
13,758 New
13,758 $169,000

Others Institutions Holding MACK

# of Institutions
2
Shares Held
349
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Kennedy Capital Management, Inc. Portfolio

Follow Kennedy Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email